Page last updated: 2024-12-06

xanthene-9-carboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

xanthene-9-carboxylic acid: degradation product of propantheline [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65736
CHEMBL ID520
CHEBI ID191142
SCHEMBL ID40617
MeSH IDM0112200

Synonyms (49)

Synonym
xanthenecarboxylic acid
82-07-5
9h-xanthene-9-carboxylic acid
nsc66208
xanthene-9-carboxylic acid
9-xanthenecarboxylic acid
xanthanoic acid
nsc-66208
SR-01000640328-1
xanthene-9-carboxylic acid, 98%
MAYBRIDGE1_006340
OPREA1_658386
inchi=1/c14h10o3/c15-14(16)13-9-5-1-3-7-11(9)17-12-8-4-2-6-10(12)13/h1-8,13h,(h,15,16
AC-11924
HMS559I04
xanthene carboxylic acid (20%)
CHEMBL520
X0031
STK801990
CHEBI:191142
AKOS000119690
nsc 66208
unii-63a81f6a8v
63a81f6a8v ,
einecs 201-394-9
BBL010931
CCG-50997
FT-0621692
PS-4501
AM20041202
xanthanoic acid [usp-rs]
9-carboxyxanthene
xanthine-9-carboxylic acid
SCHEMBL40617
DTXSID70231501
9-xanthenylcarboxylic acid
W-104189
RH 00001
STR04914
CS-W020578
mfcd00005059
xanthene-?9-?carboxylic acid
F2191-0100
xanthanoic acid, united states pharmacopeia (usp) reference standard
Q27263597
EN300-19838
9~{h}-xanthene-9-carboxylic acid
UJQ ,
Z104475708
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
xanthenes
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID226399Muscarinic receptor binding comparison to QNB, Relative binding index(RBI)1982Journal of medicinal chemistry, Sep, Volume: 25, Issue:9
Analogues of 3-quinuclidinyl benzilate.
AID142898Inhibition of (-)-[3H]-QNB muscarinic acetylcholine receptor binding on rat/ dog ventricular muscle1982Journal of medicinal chemistry, Sep, Volume: 25, Issue:9
Analogues of 3-quinuclidinyl benzilate.
AID1877819Antiproliferative activity against human A-431 cells overexpressing EGFR assessed as reduction in cell survival at 10 uM2022Bioorganic & medicinal chemistry letters, 02-15, Volume: 58Discovery of potent antiproliferative agents from selected oxygen heterocycles as EGFR tyrosine kinase inhibitors from the U.S. National Cancer Institute database by in silico screening and bioactivity evaluation.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (33.33)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's3 (33.33)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.32 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]